Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Anticancer Research
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Anticancer Research

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Visit us on Facebook
  • Follow us on Linkedin
Research ArticleClinical Studies

Comparison of Laparoscopic and Open Surgery for Colorectal Cancer in Patients with Severe Comorbidities

MASAKATSU NUMATA, SHO SAWAZAKI, JUNYA MORITA, YUKIO MAEZAWA, SHINYA AMANO, TORU AOYAMA, TSUTOMU SATO, TAKASHI OSHIMA, HIROYUKI MUSHIAKE, NORIO YUKAWA, MANABU SHIOZAWA, YASUSHI RINO and MUNETAKA MASUDA
Anticancer Research February 2018, 38 (2) 963-967;
MASAKATSU NUMATA
1Department of Surgery, Yokohama City University, Yokohama, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: masakatsunumata@hotmail.co.jp
SHO SAWAZAKI
1Department of Surgery, Yokohama City University, Yokohama, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
JUNYA MORITA
1Department of Surgery, Yokohama City University, Yokohama, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
YUKIO MAEZAWA
1Department of Surgery, Yokohama City University, Yokohama, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
SHINYA AMANO
1Department of Surgery, Yokohama City University, Yokohama, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
TORU AOYAMA
1Department of Surgery, Yokohama City University, Yokohama, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
TSUTOMU SATO
1Department of Surgery, Yokohama City University, Yokohama, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
TAKASHI OSHIMA
1Department of Surgery, Yokohama City University, Yokohama, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
HIROYUKI MUSHIAKE
1Department of Surgery, Yokohama City University, Yokohama, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
NORIO YUKAWA
1Department of Surgery, Yokohama City University, Yokohama, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
MANABU SHIOZAWA
2Department Gastroenterological Surgery, Kanagawa Cancer Center Hospital, Yokohama, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
YASUSHI RINO
1Department of Surgery, Yokohama City University, Yokohama, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
MUNETAKA MASUDA
1Department of Surgery, Yokohama City University, Yokohama, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Abstract

Background/Aim: To evaluate the safety of laparoscopic colorectal cancer surgery for patients with severe comorbidities. Patients and Methods: A total of 203 consecutive patients with severe comorbidities who underwent resection for colorectal cancer were retrospectively divided into laparoscopic and open primary resection groups. An age-adjusted Charlson comorbidity index ≥6 was considered as severe comorbidity. Results: Blood loss (31 g vs. 207 g, p<0.01) and total postoperative complications (10.0% vs. 27.5%, p<0.01) in the laparoscopic group were significantly decreased compared to the open group. Incidence of postoperative ileus (0.0% vs. 7.2%, p=0.06) and length of postoperative hospital stay (11 days vs. 14 days, p=0.08) in the laparoscopic group were improved, though not significantly, compared to the open group. Conclusion: Laparoscopic resection for patients with severe comorbidities is safe, and is associated with a lower rate of overall operative complications compared to open surgery.

  • Colorectal cancer
  • laparoscopic surgery
  • comorbidity
  • age-adjusted Charlson comorbidity index

The benefits of laparoscopic surgery for colorectal cancer have been well established. These benefits include earlier recovery of bowel function, a lower rate of intra-abdominal adhesions, reduced analgesic requirements, decreased hospital stay, and a reduced morbidity rate (1-5). However, laparoscopic surgery performed with pneumoperitoneum and using the Trendelenburg position is associated with adverse effects on hemodynamic and respiratory status, such as increasing systemic vascular resistance, decreasing the ejection fraction, and respiratory compliance (6). Due to concern for these adverse aspects, laparoscopic surgery is not generally considered for patients with a severe comorbidity. Thus, there have been few reports regarding the outcomes of patients with severe comorbidities undergoing laparoscopic colorectal surgery, and only a limited number of studies have tried to address the problem.

The Charlson Comorbidity Index (CCI) is comprised of 19 disease conditions, each assigned with a weighted score (7), and has been validated as an effective predictor of patient outcome in colorectal cancer (8-11). The age-adjusted CCI (ACCI) is a modification that considers age as an additional comorbidity factor (12) (Table I). ACCI has also been widely used as a predictive tool in various diseases (13-16). According to a previous study, an ACCI score ≥6 was considered a severe comorbidity (13, 17).

In this study, the safety of laparoscopic colorectal resection in patients with severe comorbidities was examined, comparing their outcomes with a similar cohort who underwent open resection in the same period. ACCI was used to categorize the patients based on severity of the comorbidities.

Patients and Methods

Patient enrollment. This study included consecutive patients who had severe comorbidities who underwent primary surgical resection for colorectal cancer in a university teaching hospital from April 2004 to March 2016. A total of 356 patients underwent primary resection for colorectal cancer in that period. A total of 39 patients were excluded because of multiple organ resection due to synchronous multiple cancers or metastasis (i.e.; synchronous hepatectomy or gastrectomy). Among the 317 remaining patients, 203 (64.0%) had ACCI ≥6, which was considered severe comorbidity. These 203 patients were then divided into those who had laparoscopic versus open primary resections (Figure 1).

The indication for laparoscopic surgery rather than open was not standardized, but generally was based on surgical experience, patient preference, and the size of the tumor. Patient data, which includes information regarding the preoperative assessment, operative outcomes, and postoperative complications, were retrospectively reviewed in a prospective database.

View this table:
  • View inline
  • View popup
  • Download powerpoint
Table I.

Age-adjusted Charlson Comorbidity Index.

All study protocols were approved by our institutional review board (No. B170700003). The details of the study protocol were provided to patients through a notice board in the hospital and published on the hospital website.

Perioperative management. The perioperative management of patients was similar in both groups. The patients underwent bowel preparation with polyethylene glycol electrolyte solution and began a diet on the third day after surgery. All patients received intravenous cefmetazole from just before the start of the operation until the day after. Deep venous thrombosis prophylaxis included a perioperative antiembolic stocking and intraoperative pneumatic calf compression for patients without peripheral vascular disease. Postoperative complications were evaluated according to the Clavien-Dindo classification (18). The criteria for patient discharge in both groups included tolerance of the diet without nausea or vomiting, passage of flatus and stool, and sufficient recovery from any postoperative complications.

Operative techniques. All operations were performed, or directly supervised, by one of 6 experienced colorectal surgeons. For the laparoscopic procedure, first access to the abdomen was usually achieved via the umbilical port. Once pneumoperitoneum was established, 4 additional ports were placed. Vessel ligation with lymph node dissection was performed, followed by mobilization of the colon. The specimen was extracted via a 4- to 6 cm umbilical incision. Bowel anastomosis was performed intracorporeally with the doubling staple technique for colorectal anastomosis, and extracorporeally at the extraction site for ileocolic and colo-colonic anastomosis. For the open colorectal resection, a midline laparotomy was the access point of choice. Mobilization of the colon was followed by ligation of the vessels, bowel resection, and bowel anastomosis. Any incision >8 cm was considered a conversion to open surgery.

Figure 1.
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure 1.

Consort diagram. ACCI: Age-adjusted Charlson Comorbidity Index.

Statistical analysis. The differences in patient characteristics, operative findings, and postoperative results were analyzed between the two groups. Comparisons between the laparoscopic and open group were made on an intent-to-treat basis. Chi-square and Fisher's exact tests were used for categorical variables. Student's t-test was used to compare continuous variables. All statistical analyses were performed with EZR (19) (Jichi Medical University, Saitama, Japan). All p-values were 2-sided, and p-values less than 0.05 were considered statistically significant.

Results

The demographic characteristics of the two groups are presented in Table II. There were no meaningful differences in terms of age, sex, body mass index, American Society of Anesthesiologists (ASA) physical status classification, comorbidity details, serum albumin, serum carcinoembryonic antigen levels, location of the tumor, and TMN stage. The mean ACCI score was significantly lower (6 vs. 7, p<0.01), and tumor diameter was significantly smaller (32 mm vs. 45 mm, p<0.01) in the laparoscopic group compared with the open group.

The operative outcomes of the two groups are summarized in Table III. The rate of conversion to open surgery for the laparoscopic group was 8.0% (4 cases). The reasons for conversions were tumor invasion to an adjacent structure in 3 cases, and severe intra-abdominal adhesion in 1 case. There was no conversion as a result of physiological intolerance of pneumoperitoneum or the Trendelenburg position. Although operative time was longer (247 min vs. 181 min, p<0.01) in the laparoscopic group, blood loss (31 g vs. 207 g, p<0.01) and postoperative complications (10.0% vs. 27.5%, p=0.01) were significantly better compared to the open group. Compared to the open group, the rate of ileus (0.0% vs. 7.2%, p=0.06) and length of the postoperative hospital stay (11 days vs. 14 days, p=0.08) tended to be better in the laparoscopic group, although not significant. Mortality was low in both groups (0.0% vs. 0.7%, p=1.00).

View this table:
  • View inline
  • View popup
  • Download powerpoint
Table II.

Demographic characteristics (n=203).

Discussion

Laparoscopic surgery offers the benefit of faster recovery for patients. However, pneumoperitoneum with carbon dioxide is associated with potential adverse pathophysiological changes, including hypercapnia, reduced venous return, increased peak airway pressure, and decrease pulmonary compliance (6). It has been reported that raised intracranial pressure, severe myopia, and/or retinal detachment are absolute contraindications for laparoscopy, whereas bullous emphysema, history of spontaneous pneumothorax, and pregnancy are relative contraindications (20). Because of the concern for potential hazards, the recommendation criteria for laparoscopy in patients with severe comorbidities have not been well defined.

Tashiro et al. (21) stratified patient comorbidity by ASA score (ASA1, ASA2-3, or ASA4) and compared the short-term results after laparoscopic resection for colorectal cancer. They reported that the incidence of postoperative complications was not significantly different for the groups. Ichikawa et al. (22). also used the ASA score for assessing the severity of comorbidities in patients who underwent resection for colorectal cancer, then compared the complication rates in 3 groups: a laparoscopic group with ASA score of 3 (LAP3), laparoscopic group with ASA score <2 (LAP2), and the open group with ASA score of 3 (OP3). They found that the total complication rate in LAP3 was similar with that seen in LAP2, and significantly lower than that seen in OP3, and concluded that laparoscopic colorectal resection can be performed safely in patients with severe comorbidities. Stocchi et al. performed a case-control analysis of the safety of laparoscopic and open surgery procedures for colorectal cancer in patients aged over 75 years (23). They reported that laparoscopic surgery was associated with significantly fewer post-operative morbidities (14.3 % for laparoscopic surgery vs. 33.3 % for open surgery; p=0.04), and decreased length of hospital stay (6.5 vs. 10.2 days; p<0.001), resulting in the determination that laparoscopic surgery is safe and beneficial for elderly patients compared with open colectomy.

As age was recognized as an independent factor for postoperative complications after colon cancer surgery (24), we used the ACCI to quantify base-line comorbidities. The ACCI is not just a weighted measure that reflects the severity of the comorbidity, but it also considers age as an important risk factor that can be used to evaluate the patient's general physical condition. Indeed, among all patients in this study, 41 (20.1%) were classified as having an ASA score of 2, and would have been excluded from analysis if the enrollment criterium was ASA class 3 or higher. As far as we know, there have been no studies that have used ACCI to categorize preoperative comorbidities, when comparing the short-term result after laparoscopic and open surgery for colorectal cancer.

View this table:
  • View inline
  • View popup
  • Download powerpoint
Table III.

Operative outcomes (n=203).

In this study, the laparoscopic group had fewer overall postoperative complications. Specifically, the laparoscopic group had fewer wound infections and a lower rate of postoperative ileus, although these differences were not statistically significant. Previous reports have shown that laparoscopic surgery is superior to open surgery in terms of wound complication (25) and ileus (26) after colorectal surgery. Our study confirmed that this superiority was preserved even in patients with severe comorbidities. It has also been previously reported that laparoscopic surgery reduces surgical trauma, resulting in improved serum interleukin and cytokine responses compared with open surgery (27), that may contribute to the favorable outcome in the laparoscopic group observed in this study.

Importantly, our results show that laparoscopic surgery was well tolerated by patients with cardiovascular or pulmonary disease, and no patient required open conversion due of intolerance of pneumoperitoneum. In a review article regarding anesthesia for laparoscopy, it was reported that the adverse cardiopulmonary effect of pneumoperitoneum becomes clinically evident when intraabdominal pressure is more than 15 mm Hg. At a pressure of less than 12 mm Hg, the venous return is augmented by increased outflow of blood from the splanchnic venous bed without potential burden on the cardiopulmonary system (20). With careful monitoring and improvement in anesthetic techniques, laparoscopic surgery may be performed safely in cases with severe comorbidities.

This study has several limitations. The first limitation is that it is retrospective and nonrandomized in design. When comparing patient backgrounds, the median ACCI scores and tumor diameters were lower in the laparoscopic group than the open group. These differences could affect the favorable result observed for the laparoscopic group. Thus, the results of this study are not generally applicable to all patients with a severe comorbidity, but only for selected patients. The second limitation is the sample size. The present study collected the data from a university teaching hospital over a 12-year period and identified 203 patients. Combined data from multiple centers are needed to confirm the results of the present study.

In conclusion, laparoscopic resection for patients with severe comorbidities is safe, and associated with a lower rate of complications compared to open surgery. A randomized retrospective study or case-matched large analysis is needed to confirm our results.

  • Received November 10, 2017.
  • Revision received December 13, 2017.
  • Accepted December 14, 2017.
  • Copyright© 2018, International Institute of Anticancer Research (Dr. George J. Delinasios), All rights reserved

References

  1. ↵
    1. Lacy AM,
    2. Garcia-Valdecasas JC,
    3. Delgado S,
    4. Castells A,
    5. Taura P,
    6. Pique JM,
    7. Visa J
    : Laparoscopy-assisted colectomy versus open colectomy for treatment of non-metastatic colon cancer: A randomised trial. Lancet 359(9325): 2224-2229, 2002.
    OpenUrlCrossRefPubMed
    1. Clinical Outcomes of Surgical Therapy Study Group,
    2. Nelson H,
    3. Sargent DJ,
    4. Wieand HS,
    5. Fleshman J,
    6. Anvari M,
    7. Stryker SJ,
    8. Beart RW Jr.,
    9. Hellinger M,
    10. Flanagan R Jr..,
    11. Peters W,
    12. Ota D
    : A comparison of laparoscopically assisted and open colectomy for colon cancer. N Engl J Med 350(20): 2050-2059, 2004.
    OpenUrlCrossRefPubMed
    1. Veldkamp R,
    2. Kuhry E,
    3. Hop WC,
    4. Jeekel J,
    5. Kazemier G,
    6. Bonjer HJ,
    7. Haglind E,
    8. Pahlman L,
    9. Cuesta MA,
    10. Msika S,
    11. Morino M,
    12. Lacy AM
    : Laparoscopic surgery versus open surgery for colon cancer: Short-term outcomes of a randomised trial. Lancet Oncol 6(7): 477-484, 2005.
    OpenUrlCrossRefPubMed
    1. Guillou PJ,
    2. Quirke P,
    3. Thorpe H,
    4. Walker J,
    5. Jayne DG,
    6. Smith AM,
    7. Heath RM,
    8. Brown JM
    : Short-term endpoints of conventional versus laparoscopic-assisted surgery in patients with colorectal cancer (mrc clasicc trial): Multicentre, randomised controlled trial. Lancet 365(9472): 1718-1726, 2005.
    OpenUrlCrossRefPubMed
  2. ↵
    1. Yamamoto S,
    2. Inomata M,
    3. Katayama H,
    4. Mizusawa J,
    5. Etoh T,
    6. Konishi F,
    7. Sugihara K,
    8. Watanabe M,
    9. Moriya Y,
    10. Kitano S
    : Short-term surgical outcomes from a randomized controlled trial to evaluate laparoscopic and open d3 dissection for stage ii/iii colon cancer: Japan clinical oncology group study jcog 0404. Ann Surg 260(1): 23-30, 2014.
    OpenUrlCrossRefPubMed
  3. ↵
    1. Harris SN,
    2. Ballantyne GH,
    3. Luther MA,
    4. Perrino AC Jr..
    : Alterations of cardiovascular performance during laparoscopic colectomy: A combined hemodynamic and echocardiographic analysis. Anesth Analg 83(3): 482-487, 1996.
    OpenUrlCrossRefPubMed
  4. ↵
    1. Charlson ME,
    2. Pompei P,
    3. Ales KL,
    4. MacKenzie CR
    : A new method of classifying prognostic comorbidity in longitudinal studies: Development and validation. J Chronic Dis 40(5): 373-383, 1987.
    OpenUrlCrossRefPubMed
  5. ↵
    1. Hines RB,
    2. Chatla C,
    3. Bumpers HL,
    4. Waterbor JW,
    5. McGwin G Jr..,
    6. Funkhouser E,
    7. Coffey CS,
    8. Posey J,
    9. Manne U
    : Predictive capacity of three comorbidity indices in estimating mortality after surgery for colon cancer. J Clin Oncol 27(26): 4339-4345, 2009.
    OpenUrlAbstract/FREE Full Text
    1. Krarup PM,
    2. Nordholm-Carstensen A,
    3. Jorgensen LN,
    4. Harling H
    : Association of comorbidity with anastomotic leak, 30-day mortality, and length of stay in elective surgery for colonic cancer: A nationwide cohort study. Dis Colon Rectum 58(7): 668-676, 2015.
    OpenUrl
    1. Marventano S,
    2. Grosso G,
    3. Mistretta A,
    4. Bogusz-Czerniewicz M,
    5. Ferranti R,
    6. Nolfo F,
    7. Giorgianni G,
    8. Rametta S,
    9. Drago F,
    10. Basile F,
    11. Biondi A
    : Evaluation of four comorbidity indices and Charlson comorbidity index adjustment for colorectal cancer patients. Int J Colorectal Dis 29(9): 1159-1169, 2014.
    OpenUrlCrossRefPubMed
  6. ↵
    1. Schneider EB,
    2. Hyder O,
    3. Brooke BS,
    4. Efron J,
    5. Cameron JL,
    6. Edil BH,
    7. Schulick RD,
    8. Choti MA,
    9. Wolfgang CL,
    10. Pawlik TM
    : Patient readmission and mortality after colorectal surgery for colon cancer: Impact of length of stay relative to other clinical factors. J Am Coll Surg 214(4): 390-398, 2012.
    OpenUrlCrossRefPubMed
  7. ↵
    1. Charlson M,
    2. Szatrowski TP,
    3. Peterson J,
    4. Gold J
    : Validation of a combined comorbidity index. J Clin Epidemiol 47(11): 1245-1251, 1994.
    OpenUrlCrossRefPubMed
  8. ↵
    1. Wu CC,
    2. Hsu TW,
    3. Chang CM,
    4. Yu CH,
    5. Lee CC
    : Age-adjusted charlson comorbidity index scores as predictor of survival in colorectal cancer patients who underwent surgical resection and chemoradiation. Medicine (Baltimore) 94(2): e431, 2015.
    OpenUrl
    1. Koppie TM,
    2. Serio AM,
    3. Vickers AJ,
    4. Vora K,
    5. Dalbagni G,
    6. Donat SM,
    7. Herr HW,
    8. Bochner BH
    : Age-adjusted Charlson comorbidity score is associated with treatment decisions and clinical outcomes for patients undergoing radical cystectomy for bladder cancer. Cancer 112(11): 2384-2392, 2008.
    OpenUrlCrossRefPubMed
    1. Robbins JR,
    2. Gayar OH,
    3. Zaki M,
    4. Mahan M,
    5. Buekers T,
    6. Elshaikh MA
    : Impact of age-adjusted Charlson comorbidity score on outcomes for patients with early-stage endometrial cancer. Gynecol Oncol 131(3): 593-597, 2013.
    OpenUrl
  9. ↵
    1. Saji M,
    2. Katz MR,
    3. Ailawadi G,
    4. Fowler DE,
    5. Ragosta M,
    6. Lim DS
    : Predictive value of age-adjusted Charlson co-morbidity index for 1-, 3-, and 5-year mortality in patients requiring transcatheter mitral valve repair. Am J Cardiol 120(2): 309-314, 2017.
    OpenUrl
  10. ↵
    1. Tian Y,
    2. Jian Z,
    3. Xu B,
    4. Liu H
    : Age-adjusted Charlson comorbidity index score as predictor of survival of patients with digestive system cancer who have undergone surgical resection. Oncotarget 8(45): 79453-79461, 2017.
    OpenUrl
  11. ↵
    1. Dindo D,
    2. Demartines N,
    3. Clavien PA
    : Classification of surgical complications: A new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg 240(2): 205-213, 2004.
    OpenUrlCrossRefPubMed
  12. ↵
    1. Kanda Y
    : Investigation of the freely available easy-to-use software ‘ezr’ for medical statistics. Bone Marrow Transplant 48(3): 452-458, 2013.
    OpenUrlCrossRefPubMed
  13. ↵
    1. Gerges FJ,
    2. Kanazi GE,
    3. Jabbour-Khoury SI
    : Anesthesia for laparoscopy: A review. J Clin Anesth 18(1): 67-78, 2006.
    OpenUrlCrossRefPubMed
  14. ↵
    1. Tashiro J,
    2. Yamaguchi S,
    3. Ishii T,
    4. Suwa H,
    5. Okada I,
    6. Kondo H,
    7. Miyazawa M,
    8. Shinozuka N,
    9. Koyama I
    : Efficacy of laparoscopic colorectal resection for risk patients with severe comorbidity. Hepatogastroenterology 59(119): 2173-2176, 2012.
    OpenUrl
  15. ↵
    1. Ichikawa N,
    2. Homma S,
    3. Nakanishi K,
    4. Kazui K,
    5. Kashiwakura S,
    6. Ohira M,
    7. Tsuji T,
    8. Suzuki T,
    9. Ishikawa T,
    10. Taketomi A
    : Safety of laparoscopic colorectal resection in patients with severe comorbidities. Surg Laparosc Endosc Percutan Tech 26(6): 503-507, 2016.
    OpenUrl
  16. ↵
    1. Stocchi L,
    2. Nelson H,
    3. Young-Fadok TM,
    4. Larson DR,
    5. Ilstrup DM
    : Safety and advantages of laparoscopic vs. Open colectomy in the elderly: Matched-control study. Dis Colon Rectum 43(3): 326-332, 2000.
    OpenUrlCrossRefPubMed
  17. ↵
    1. Aquina CT,
    2. Mohile SG,
    3. Tejani MA,
    4. Becerra AZ,
    5. Xu Z,
    6. Hensley BJ,
    7. Arsalani-Zadeh R,
    8. Boscoe FP,
    9. Schymura MJ,
    10. Noyes K,
    11. Monson JR,
    12. Fleming FJ
    : The impact of age on complications, survival, and cause of death following colon cancer surgery. Br J Cancer 116(3): 389-397, 2017.
    OpenUrl
  18. ↵
    1. Abraham NS,
    2. Young JM,
    3. Solomon MJ
    : Meta-analysis of short-term outcomes after laparoscopic resection for colorectal cancer. Br J Surg 91(9): 1111-1124, 2004.
    OpenUrlCrossRefPubMed
  19. ↵
    1. Reza MM,
    2. Blasco JA,
    3. Andradas E,
    4. Cantero R,
    5. Mayol J
    : Systematic review of laparoscopic versus open surgery for colorectal cancer. Br J Surg 93(8): 921-928, 2006.
    OpenUrlCrossRefPubMed
  20. ↵
    1. Evans C,
    2. Galustian C,
    3. Kumar D,
    4. Hagger R,
    5. Melville DM,
    6. Bodman-Smith M,
    7. Jourdan I,
    8. Gudgeon AM,
    9. Dalgleish AG
    : Impact of surgery on immunologic function: Comparison between minimally invasive techniques and conventional laparotomy for surgical resection of colorectal tumors. Am J Surg 197(2): 238-245, 2009.
    OpenUrlCrossRefPubMed
PreviousNext
Back to top

In this issue

Anticancer Research: 38 (2)
Anticancer Research
Vol. 38, Issue 2
February 2018
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Back Matter (PDF)
  • Ed Board (PDF)
  • Front Matter (PDF)
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Anticancer Research.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Comparison of Laparoscopic and Open Surgery for Colorectal Cancer in Patients with Severe Comorbidities
(Your Name) has sent you a message from Anticancer Research
(Your Name) thought you would like to see the Anticancer Research web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
5 + 1 =
Solve this simple math problem and enter the result. E.g. for 1+3, enter 4.
Citation Tools
Comparison of Laparoscopic and Open Surgery for Colorectal Cancer in Patients with Severe Comorbidities
MASAKATSU NUMATA, SHO SAWAZAKI, JUNYA MORITA, YUKIO MAEZAWA, SHINYA AMANO, TORU AOYAMA, TSUTOMU SATO, TAKASHI OSHIMA, HIROYUKI MUSHIAKE, NORIO YUKAWA, MANABU SHIOZAWA, YASUSHI RINO, MUNETAKA MASUDA
Anticancer Research Feb 2018, 38 (2) 963-967;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Reprints and Permissions
Share
Comparison of Laparoscopic and Open Surgery for Colorectal Cancer in Patients with Severe Comorbidities
MASAKATSU NUMATA, SHO SAWAZAKI, JUNYA MORITA, YUKIO MAEZAWA, SHINYA AMANO, TORU AOYAMA, TSUTOMU SATO, TAKASHI OSHIMA, HIROYUKI MUSHIAKE, NORIO YUKAWA, MANABU SHIOZAWA, YASUSHI RINO, MUNETAKA MASUDA
Anticancer Research Feb 2018, 38 (2) 963-967;
Reddit logo Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Patients and Methods
    • Results
    • Discussion
    • References
  • Figures & Data
  • Info & Metrics
  • PDF

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

  • Primary Synovial Sarcoma of the Bone: A Case Report and Literature Review
  • Melanoma of the Lower Limbs and Hips: A Surveillance, Epidemiology, and End Results Analysis of Epidemiology and Survival 2000-2019
  • Ganglioside GD2 Expression Is Associated With Unfavorable Prognosis in Early Triple-negative Breast Cancer
Show more Clinical Studies

Similar Articles

Keywords

  • Colorectal cancer
  • laparoscopic surgery
  • comorbidity
  • age-adjusted Charlson comorbidity index
Anticancer Research

© 2023 Anticancer Research

Powered by HighWire